S&P 500 7,628.29 â–ŧ 57.85 (-0.75%) DOW 52,759.94 â–ŧ 425.96 (-0.80%) NASDAQ 26,096.35 â–ŧ 274.54 (-1.04%) US Markets Closed â€ĸ 07:54 PM ET

ANL

Adlai Nortye Group Ltd.

Price Chart

No historical data available

Latest Quote

$13.65

-0.67 (-4.68%)
Current Price
Previous Close $14.32
Open $14.41
Day High $14.45
Day Low $13.63
Volume 74,868
Fetched: 2026-08-28T16:53:25
Stock Information
Shares Outstanding 58.73M
Total Debt $26.70M
Cash Equivalents $232.82M
Revenue $18.06M
Net Income $-22.53M
Sector Healthcare
Industry Biotechnology
Market Cap $889.98M
EPS (TTM) $-0.64
Exchange NGM
🌐 Visit Website
Recent Price History
No history data available. Data will be fetched automatically.
About Adlai Nortye Group Ltd.

Adlai Nortye Group Ltd., a clinical-stage biopharmaceutical company, engages in the discovery and development of cancer therapies. The company's pipeline centers on RAS-targeting therapies and next-generation cancer immunotherapies. Its RAS-targeting programs include AN9025, an oral pan-RAS(ON) inhibitor for RAS-driven cancers, and AN4035, a CEACAM5-targeting antibody-drug conjugate that delivers a pan-RAS(ON) inhibitor to tumors. Its immunotherapy programs include AN8025, a tri-functional fusion protein (aPD-L1 x CD86 variant x LAG3 variant) that modulates T-cells and antigen-presenting cells; AN0025, a small molecule EP4 antagonist; and AN4005, an oral small-molecule PD-L1 inhibitor. The company supports its pipeline through an immuno-oncology research and development platform with operations in the United States and China. Adlai Nortye Group Ltd. was formerly known as Adlai Nortye Ltd. and changed its name to Adlai Nortye Group Ltd. in July, 2026. Adlai Nortye Group Ltd. was founded in 2004 and is based in North Brunswick, New Jersey.

📰 Latest News
No news articles available at the moment. Check back later for updates on ANL.
Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Total Revenue $5,000,000 $0 $0 $0
Operating Revenue $5,000,000 $0 $0 $0
Expenses
Interest Expense $1,488,000 $1,944,000 $791,000 $433,000
Total Expenses $40,698,000 $52,928,000 $72,551,000 $67,270,000
Other Income Expense $1,701,000 $3,003,000 $-35,886,000 $8,913,000
Other Non Operating Income Expenses $1,703,000 $3,007,000 $-35,948,000 $7,879,000
Net Non Operating Interest Income Expense $-1,531,000 $-1,944,000 $-791,000 $-433,000
Total Other Finance Cost $43,000 - - -
Interest Expense Non Operating $1,488,000 $1,944,000 $791,000 $433,000
Operating Expense $40,698,000 $52,928,000 $72,551,000 $67,270,000
Other Operating Expenses $-396,000 $-1,940,000 $-890,000 $-259,000
General And Administrative Expense $7,785,000 $9,443,000 $14,824,000 $12,430,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-35,528,000 $-51,869,000 $-109,228,000 $-58,790,000
Net Interest Income $-1,531,000 $-1,944,000 $-791,000 $-433,000
Normalized Income $-35,529,000 $-51,869,000 $-109,290,000 $-59,824,000
Net Income From Continuing And Discontinued Operation $-35,528,000 $-51,869,000 $-109,228,000 $-58,790,000
Total Operating Income As Reported $-35,698,000 $-52,928,000 $-72,551,000 $-67,270,000
Net Income Common Stockholders $-35,528,000 $-51,869,000 $-109,228,000 $-58,790,000
Net Income $-35,528,000 $-51,869,000 $-109,228,000 $-58,790,000
Net Income Including Noncontrolling Interests $-35,528,000 $-51,869,000 $-109,228,000 $-58,790,000
Net Income Continuous Operations $-35,528,000 $-51,869,000 $-109,228,000 $-58,790,000
Pretax Income $-35,528,000 $-51,869,000 $-109,228,000 $-58,790,000
Earnings From Equity Interest $-3,000 $-4,000 $0 $0
Operating Income $-35,698,000 $-52,928,000 $-72,551,000 $-67,270,000
Depreciation Amortization Depletion Income Statement $476,000 $510,000 $465,000 $609,000
Depreciation And Amortization In Income Statement $476,000 $510,000 $465,000 $609,000
Interest Income - - $62,000 $550,000
Interest Income Non Operating - - $62,000 $550,000
Per Share
Diluted EPS $-1.11 $-1.62 $-7.56 $-1.59
Basic EPS $-1.11 $-1.62 $-7.56 $-1.59
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-32,628,000 $-48,055,000 $-106,277,000 $-57,350,000
Total Unusual Items $1,000 - $62,000 $1,034,000
Total Unusual Items Excluding Goodwill $1,000 - $62,000 $1,034,000
Reconciled Depreciation $1,413,000 $1,870,000 $2,222,000 $2,041,000
EBITDA (Bullshit earnings) $-32,627,000 $-48,055,000 $-106,215,000 $-56,316,000
EBIT $-34,040,000 $-49,925,000 $-108,437,000 $-58,357,000
Diluted Average Shares $31,974,472 $31,925,569 $14,447,356 $36,900,268
Basic Average Shares $31,974,472 $31,925,569 $14,447,356 $36,900,268
Diluted NI Availto Com Stockholders $-35,528,000 $-51,869,000 $-109,228,000 $-58,790,000
Tax Provision $0 $0 $0 $0
Gain On Sale Of Security $1,000 - $62,000 $1,034,000
Research And Development $32,833,000 $44,915,000 $58,152,000 $54,490,000
Selling General And Administration $7,785,000 $9,443,000 $14,824,000 $12,430,000
Other Gand A $2,977,000 $3,449,000 $8,651,000 $4,230,000
Salaries And Wages $4,808,000 $5,994,000 $6,173,000 $8,200,000
Fetched: 2026-08-27
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $-8,341,000 $25,445,000 $74,983,000 $-241,382,000
Total Assets $34,433,000 $71,270,000 $130,189,000 $72,594,000
Total Non Current Assets $7,541,000 $7,206,000 $28,994,000 $6,291,000
Other Non Current Assets $253,000 $304,000 $282,000 $327,000
Goodwill And Other Intangible Assets $19,000 $40,000 $63,000 $89,000
Other Intangible Assets $19,000 $40,000 $63,000 $89,000
Current Assets $26,892,000 $64,064,000 $101,195,000 $66,303,000
Restricted Cash $15,730,000 $0 - -
Prepaid Assets $1,716,000 $1,981,000 $2,337,000 $1,912,000
Receivables $1,390,000 $1,174,000 $359,000 $346,000
Other Receivables $907,000 $250,000 $224,000 $246,000
Taxes Receivable $468,000 $910,000 $135,000 $100,000
Cash Cash Equivalents And Short Term Investments $8,056,000 $60,909,000 $98,499,000 $64,045,000
Cash And Cash Equivalents $8,056,000 $60,902,000 $91,492,000 $42,758,000
Cash Financial $8,056,000 $60,902,000 $91,492,000 -
Non Current Prepaid Assets - $304,000 $0 $0
Investmentin Financial Assets - $0 $24,849,000 $0
Non Current Accounts Receivable - - - -
Debt
Net Debt $16,526,000 - - -
Total Debt $26,376,000 $27,226,000 $31,548,000 $6,544,000
Long Term Debt And Capital Lease Obligation $1,127,000 $425,000 $469,000 $1,236,000
Current Debt And Capital Lease Obligation $25,249,000 $26,801,000 $31,079,000 $5,308,000
Current Debt $24,582,000 $26,330,000 $30,357,000 $4,307,000
Liabilities
Total Liabilities Net Minority Interest $42,755,000 $45,785,000 $55,143,000 $313,887,000
Total Non Current Liabilities Net Minority Interest $1,127,000 $425,000 $5,469,000 $1,236,000
Current Liabilities $41,628,000 $45,360,000 $49,674,000 $312,651,000
Current Deferred Liabilities $0 $5,000,000 $0 -
Payables And Accrued Expenses $16,379,000 $13,559,000 $18,595,000 $16,975,000
Payables $13,235,000 $10,496,000 $14,781,000 $13,353,000
Other Payable $579,000 $275,000 $303,000 $255,000
Total Tax Payable $18,000 $75,000 $130,000 -
Accounts Payable $12,638,000 $10,146,000 $14,348,000 $13,098,000
Non Current Deferred Liabilities - $0 $5,000,000 -
Other Current Liabilities - - - $290,368,000
Derivative Product Liabilities - - - -
Equity
Common Stock Equity $-8,322,000 $25,485,000 $75,046,000 $-252,273,000
Total Equity Gross Minority Interest $-8,322,000 $25,485,000 $75,046,000 $-241,293,000
Stockholders Equity $-8,322,000 $25,485,000 $75,046,000 $-241,293,000
Other Equity Interest $21,592,000 $20,311,000 $18,018,000 $13,688,000
Gains Losses Not Affecting Retained Earnings $-4,346,000 $-4,535,000 $-4,241,000 $-4,159,000
Retained Earnings $-464,846,000 $-429,318,000 $-377,449,000 $-268,221,000
Long Term Equity Investment $4,249,000 $4,157,000 $0 -
Preferred Stock Equity - - - $10,980,000
Preferred Securities Outside Stock Equity - - - -
Other
Ordinary Shares Number $176,221,572 $110,700,803 $110,700,805 $110,700,805
Share Issued $176,221,572 $110,700,803 $110,700,805 $110,700,805
Tangible Book Value $-8,341,000 $25,445,000 $74,983,000 $-252,362,000
Invested Capital $16,260,000 $51,815,000 $105,403,000 $-247,966,000
Working Capital $-14,736,000 $18,704,000 $51,521,000 $-246,348,000
Capital Lease Obligations $1,794,000 $896,000 $1,191,000 $2,237,000
Total Capitalization $-8,322,000 $25,485,000 $75,046,000 $-241,293,000
Foreign Currency Translation Adjustments $-4,346,000 $-4,535,000 $-4,241,000 $-4,159,000
Additional Paid In Capital $439,266,000 $439,016,000 $438,707,000 $6,415,000
Capital Stock $12,000 $11,000 $11,000 $10,984,000
Common Stock $12,000 $11,000 $11,000 $4,000
Long Term Capital Lease Obligation $1,127,000 $425,000 $469,000 $1,236,000
Current Deferred Revenue $0 $5,000,000 $0 -
Current Capital Lease Obligation $667,000 $471,000 $722,000 $1,001,000
Line Of Credit $24,582,000 $26,330,000 $30,357,000 $4,307,000
Current Accrued Expenses $3,144,000 $3,063,000 $3,814,000 $3,622,000
Investments And Advances $4,249,000 $4,157,000 $24,849,000 $0
Net PPE $3,020,000 $2,705,000 $3,800,000 $5,875,000
Accumulated Depreciation $-4,453,000 $-3,637,000 $-3,944,000 $-2,830,000
Gross PPE $7,473,000 $6,342,000 $7,744,000 $8,705,000
Leases $2,466,000 $2,241,000 $2,519,000 $2,532,000
Other Properties $262,000 $257,000 $228,000 $276,000
Machinery Furniture Equipment $2,944,000 $2,889,000 $3,865,000 $3,811,000
Buildings And Improvements $1,801,000 $955,000 $1,132,000 $2,086,000
Properties $0 $0 $0 $0
Duefrom Related Parties Current $15,000 $14,000 $0 -
Other Short Term Investments $0 $7,000 $7,007,000 $21,287,000
Preferred Stock - $0 $0 $10,980,000
Non Current Deferred Revenue - $0 $5,000,000 -
Available For Sale Securities - - $24,849,000 -
Fetched: 2026-08-27
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-33,639,000 $-51,989,000 $-56,852,000 $-44,491,000
Operating Activities
Operating Cash Flow $-33,452,000 $-51,819,000 $-56,652,000 $-43,223,000
Cash Flow From Continuing Operating Activities $-33,452,000 $-51,819,000 $-56,652,000 $-43,223,000
Operating Gains Losses $2,000 $27,000 $-62,000 $-557,000
Investing Activities
Capital Expenditure $-187,000 $-170,000 $-200,000 $-1,268,000
Investing Cash Flow $-15,579,000 $28,065,000 $-10,954,000 $28,376,000
Cash Flow From Continuing Investing Activities $-15,579,000 $28,065,000 $-10,954,000 $28,376,000
Net Other Investing Changes - - - $550,000
Financing Activities
Issuance Of Capital Stock $0 $0 $91,780,000 $0
Financing Cash Flow $-3,812,000 $-6,579,000 $116,240,000 $-6,780,000
Cash Flow From Continuing Financing Activities $-3,812,000 $-6,579,000 $116,240,000 $-6,780,000
Cash Dividends Paid $0 $0 $0 $0
Net Common Stock Issuance $0 $0 $91,780,000 $0
Common Stock Issuance $0 $0 $91,780,000 $0
Net Other Financing Charges - - - -
Other
Repayment Of Debt $-40,362,000 $-49,562,000 $-25,172,000 $-14,385,000
Issuance Of Debt $37,719,000 $44,702,000 $50,234,000 $7,897,000
End Cash Position $8,056,000 $60,902,000 $91,492,000 $42,758,000
Beginning Cash Position $60,902,000 $91,492,000 $42,758,000 $64,131,000
Effect Of Exchange Rate Changes $-3,000 $-257,000 $100,000 $254,000
Changes In Cash $-52,843,000 $-30,333,000 $48,634,000 $-21,627,000
Interest Paid Cff $-1,169,000 $-1,871,000 $-602,000 $-292,000
Proceeds From Stock Option Exercised $0 $152,000 $0 $0
Net Issuance Payments Of Debt $-2,643,000 $-4,860,000 $25,062,000 $-6,488,000
Net Short Term Debt Issuance $-2,010,000 $-3,840,000 $26,165,000 $-5,418,000
Short Term Debt Payments $-39,729,000 $-48,542,000 $-24,069,000 $-13,315,000
Short Term Debt Issuance $37,719,000 $44,702,000 $50,234,000 $7,897,000
Net Long Term Debt Issuance $-633,000 $-1,020,000 $-1,103,000 $-1,070,000
Long Term Debt Payments $-633,000 $-1,020,000 $-1,103,000 $-1,070,000
Interest Received Cfi $1,000 $701,000 $62,000 $550,000
Net Investment Purchase And Sale $-15,393,000 $31,713,000 $-10,817,000 $29,077,000
Sale Of Investment $5,039,000 $92,259,000 $21,039,000 $88,057,000
Purchase Of Investment $-20,432,000 $-60,546,000 $-31,856,000 $-58,980,000
Net Business Purchase And Sale $0 $-4,212,000 $0 $0
Purchase Of Business $0 $-4,212,000 $0 $0
Net PPE Purchase And Sale $-187,000 $-137,000 $-199,000 $-1,232,000
Sale Of PPE $0 $33,000 $1,000 $17,000
Purchase Of PPE $-187,000 $-170,000 $-200,000 $-1,249,000
Change In Working Capital $-2,286,000 $-5,540,000 $6,124,000 $15,247,000
Change In Other Working Capital $-5,000,000 - $5,000,000 -
Change In Other Current Assets $51,000 $-22,000 $45,000 $128,000
Change In Payables And Accrued Expense $2,498,000 $-5,058,000 $1,515,000 $10,773,000
Change In Payable $2,498,000 $-5,058,000 $1,515,000 $10,773,000
Change In Account Payable $2,491,000 $-4,202,000 $1,252,000 $10,117,000
Change In Prepaid Assets $165,000 $-460,000 $-436,000 $4,346,000
Other Non Cash Items $1,415,000 $1,243,000 $791,000 $433,000
Stock Based Compensation $1,532,000 $2,450,000 $4,330,000 $6,082,000
Unrealized Gain Loss On Investment Securities $0 $0 $39,171,000 $-7,679,000
Depreciation Amortization Depletion $1,413,000 $1,870,000 $2,222,000 $2,041,000
Depreciation And Amortization $1,413,000 $1,870,000 $2,222,000 $2,041,000
Amortization Cash Flow $22,000 $22,000 $25,000 $20,000
Amortization Of Intangibles $22,000 $22,000 $25,000 $20,000
Depreciation $1,391,000 $1,848,000 $2,197,000 $2,021,000
Earnings Losses From Equity Investments $3,000 $4,000 $0 $0
Gain Loss On Investment Securities $-1,000 - $-62,000 $-550,000
Gain Loss On Sale Of PPE $0 $23,000 $0 $-7,000
Net Income From Continuing Operations $-35,528,000 $-51,869,000 $-109,228,000 $-58,790,000
Net Intangibles Purchase And Sale - $0 $0 $-19,000
Purchase Of Intangibles - $0 $0 $-19,000
Interest Received Cfo - $0 $-62,000 $-550,000
Interest Paid Cfo - $0 $-62,000 $-550,000
Fetched: 2026-08-27